SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRtw Biotech Regulatory News (RTW)

Share Price Information for Rtw Biotech (RTW)

Share Price is delayed by 15 minutes
Get Live Data
2.21    0.00 (0.00%)
Bid:
2.19
Ask:
2.21
Spread: 0.02 (0.913%)
Market Cap: $714.60m
RTW Live PriceLast checked at - London Stock Exchange

Intraday Rtw Biotech Share Chart

QuotedData's Weekly News & Interview

26 Jan 2023 11:32

RNS Number : 9947N
RTW Venture Fund Limited
26 January 2023
 

QuotedData's Investment Trust Weekly News Round-up Show - Stephanie Sirota from RTW Venture Fund

On the 20th January, James Carthew talked through the Weekly News and interviewed Stephanie Sirota from RTW Venture Fund - Watch here.

About our Weekly Show:

The best way to enjoy the show is to join our weekly webinar live, at 11 am every Friday, where we discuss the key stories and events in the investment companies' sector over the last week. We also invite a guest every week and give you the opportunity to get answers to your questions.

Click here to view our previous recordings: https://quoteddata.com/events/?past=true

Click here to view our upcoming events: https://quoteddata.com/events/

This information is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

This website is for information purposes only and is not intended to encourage the reader to deal in any mentioned securities. QuotedData is a trading name of Marten & Co Limited, which is authorised and regulated by the Financial Conduct Authority. Some of the content in this website is sponsored and, although it abides by Content Principles and Objectives, (/about-quoteddata/research-principles-objectives/) it is considered non-independent. Investments may involve a significant degree of risk, including loss of capital. The value of an investment and the income from it could go down as well as up. The return of your investment is not guaranteed, and you may get back less than you originally invested. Past performance is not an indicator of future performance. It is important that you read the Terms and Conditions (/about-quoteddata/terms-and-conditions/) before considering any investment.

QUOTEDDATA50 Gresham Street | London | EC2V 7AY | UKTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABBGDBGXDDGXL
Date   Source Headline
27th Sep 20247:00 amRNSBioAge Labs completes $198 million IPO
26th Sep 20247:00 amRNSGBP quote for the share class to cease
16th Sep 20247:00 amRNSMonthly Valuation Update and Factsheet
13th Sep 20247:00 amRNSHalf-year Report
14th Aug 20247:01 amRNSClosed Period Notification
14th Aug 20247:00 amRNSMonthly Valuation Update and Factsheet
6th Aug 20247:00 amRNSNew Investment in Jade Biosciences, Inc
22nd Jul 202412:00 pmRNSArtiva Biotherapeutics prices IPO at $167 million
15th Jul 20247:00 amRNSMonthly Valuation Update and Factsheet
11th Jul 20247:00 amRNSBaroness Blackwood Appointed as Independent NED
2nd Jul 20247:00 amRNSInvestment in Mirador Therapeutics & Santa Ana Bio
1st Jul 20247:00 amRNSTotal Voting Rights
14th Jun 20247:00 amRNSMonthly Valuation Update and Factsheet
13th Jun 20247:00 amRNSPositive Data Announcement - Avidity Biosciences
11th Jun 20247:00 amRNSPortfolio Company Numab Therapeutics Update
5th Jun 20247:00 amRNSTransaction in Own Shares
3rd Jun 20247:00 amRNSTotal Voting Rights
31st May 202412:00 pmRNSDirector Declaration
31st May 20247:00 amRNSTransaction in Own Shares
29th May 20247:00 amRNSHolding(s) in Company
28th May 20247:00 amRNSHolding(s) in Company
24th May 202412:00 pmRNSCancellation of Own Shares
16th May 20244:47 pmRNSResult of AGM
15th May 20247:01 amRNSTransaction in Own Shares
15th May 20247:00 amRNSAdditional Investment in Lycia Therapeutics
14th May 20247:00 amRNSMonthly Valuation Update and Factsheet
1st May 20247:01 amRNSTotal Voting Rights
1st May 20247:00 amRNSTransaction in Own Shares
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20244:46 pmRNSAnnual Financial Report
24th Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20249:30 amRNSNotice of AGM
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSMonthly Valuation Update and First Quarter Letter
12th Apr 20245:42 pmRNSPortfolio Company Update: Artios Pharma
12th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 202410:00 amRNSNew Investment: Obsidian Therapeutics
5th Apr 20247:01 amRNSTransaction in Own Shares
4th Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20247:01 amRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20247:01 amRNSTransaction in Own Shares
28th Mar 20247:00 amRNSAnnual Financial Report
27th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20247:00 amRNSTransaction in Own Shares
15th Mar 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.